Metropolis Healthcare Q2 profit jumps 42.7%, revenue rises

Metropolis Healthcare Q2 profit rises 42.7% and revenue grows 15.8%. Shares show improving momentum, with Rs 537–510 support and Rs 610 resistance. Metropolis Healthcare Limited [

] shares were in focus on 4 November 2026 after the company reported strong consolidated Q2 results. Profit increased 42.7% year on year to Rs 75.5 crore, compared with Rs 52.9 crore in the corresponding quarter last year. Revenue also grew 15.8% to Rs 496.8 crore from Rs 429.2 crore. Profit growth remained significantly stronger than revenue growth. From a technical perspective, the daily chart indicates a sideways market structure, although recent price action shows improving upward momentum. Following a deep correction from its earlier peak, the stock formed a base and gradually recovered through higher lows. The recent high near Rs 610 remains an important resistance. On the downside, the Rs 537–510 zone forms a crucial support area. The near-term momentum has turned positive, and a sustained move towards and above Rs 610 could strengthen the bullish outlook. However, holding the support zone remains important to maintain the recovery. Stance: Sideways trend with improving upside momentum. Support at Rs 537–510 and resistance at Rs 610. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.